This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
The article entitled, "Treatment of Trichinosis" (Arch Ophthal 71:359-363, 1964), by Spaeth et al, is most interesting. In view of the fact that they claim this to be the first human case treated, a correction of dosage becomes important for the guidance of those who may wish to use thiabendazole in the treatment of trichinosis and possibly other larval helminthic infestations (cutaneous and visceral larva migrans).The regimen of therapy used by Spaeth et al was 0.5 gm every 12 hours for seven consecutive days. On page 362 they stated that the drug "was prescribed in a dose of 1,000 mg a day (60 mg/kg/day), divided into two equal doses, for a period of seven days." Their patient was a 22-year-old, well-developed female student of Lithuanian extraction. Although her actual body weight was not given, she probably weighed 50 or 60 kg, in which case the daily
Berberian DA. TREATMENT OF TRICHINOSIS. Arch Ophthalmol. 1965;73(1):147. doi:https://doi.org/10.1001/archopht.1965.00970030149032
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: